News

BIOTRONIK has announced CE approval for its new Edora pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps). Edora devices feature the company’s ProMRI® technology, including the MRI AutoDetect sensor. This approval means that...

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) Exclusion System, which offers...

Medtronic plc announced availability of its Beacon Heart Failure Management Service in the United States. This new service from Medtronic Care Management Services (MCMS) combines data from Medtronic implantable cardioverter defibrillator...

CorMatrix® Cardiovascular Incorporated, a company specializing in its extracellular matrix (ECM®) technology announced that it has received CE mark approval for its CorMatrix® CanGaroo® ECM® Envelope. It is intended for use with cardiac...

ABBOTT PARK, Ill., June. 22, 2016 — Abbott announced today positive results from three clinical studies investigating the benefits associated with focal impulse rotor modulation (FIRM)-guided rotor ablation for atrial fibrillation. The...

BIOTRONIK announced the commercial launch of Solia S ProMRI®, with a 5.6 French lead body, the smallest MR conditional pacing lead available in the United States. Solia S ProMRI is available in 45, 53 and 60 centimeter lengths. Solia...

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced that patients experience a high one-year survival rate following use of the LifeVest® Wearable Defibrillator....

Medtronic plc announced findings from the secondary analyses of the FIRE AND ICE clinical trial that demonstrate significantly fewer repeat ablations and lower hospitalization rates for patients with paroxysmal atrial fibrillation (PAF)...

Mayne Pharma Inc. has received approval from the U.S. Food and Drug Administration (FDA) to market dofetilide capsules, a generic alternative to Tikosyn®, an anti-arrhythmic agent used to treat irregular heartbeats, such as atrial...

Milwaukee, Wis. – Physicians from Aurora St. Luke’s Medical Center have streamlined a new treatment option for patients suffering from atrial fibrillation (AFib) that has proven to reduce the risks of stroke and heart failure compared to...